Pinku Mukherjee
Affiliations: | Biology (PhD) | University of North Carolina, Charlotte, Charlotte, NC, United States |
Area:
Cell Biology, Oncology, Molecular BiologyGoogle:
"Pinku Mukherjee"Children
Sign in to add trainee| Mahnaz SahraeiManouchehrAbadi | grad student | 2011 | UNC Charlotte |
| Dahlia M. Besmer | grad student | 2013 | UNC Charlotte |
| Sritama Nath | grad student | 2013 | UNC Charlotte |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bose M, Sanders A, Handa A, et al. (2024) Molecular crosstalk between MUC1 and STAT3 influences the anti-proliferative effect of Napabucasin in epithelial cancers. Scientific Reports. 14: 3178 |
| Zhou R, Wu ST, Yazdanifar M, et al. (2024) Mucin-1-Targeted Chimeric Antigen Receptor T Cells Are Effective and Safe in Controlling Solid Tumors in Immunocompetent Host. Journal of Immunotherapy (Hagerstown, Md. : 1997) |
| Bose M, Sanders A, De C, et al. (2022) Targeting tumor-associated MUC1 overcomes anoikis-resistance in pancreatic cancer. Translational Research : the Journal of Laboratory and Clinical Medicine |
| Tarannum M, Holtzman K, Dréau D, et al. (2022) Nanoparticle combination for precise stroma modulation and improved delivery for pancreatic cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. 347: 425-434 |
| Bose M, Grover P, Sanders AJ, et al. (2022) Overexpression of MUC1 Induces Non-Canonical TGF-β Signaling in Pancreatic Ductal Adenocarcinoma. Frontiers in Cell and Developmental Biology. 10: 821875 |
| Sahraei M, Bose M, Sanders JA, et al. (2021) Repression of MUC1 Promotes Expansion and Suppressive Function of Myeloid-Derived Suppressor Cells in Pancreatic and Breast Cancer Murine Models. International Journal of Molecular Sciences. 22 |
| Zhou R, Yazdanifar M, Roy LD, et al. (2020) Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth. Frontiers in Immunology. 11: 628776 |
| Kelly VJ, Wu ST, Gottumukkala V, et al. (2020) Preclinical evaluation of an In/Ac theranostic targeting transformed MUC1 for triple negative breast cancer. Theranostics. 10: 6946-6958 |
| Bose M, Mukherjee P. (2019) Microbe-MUC1 Crosstalk in Cancer-Associated Infections. Trends in Molecular Medicine |
| Curry JM, Besmer DM, Erick TK, et al. (2019) Indomethacin enhances anti-tumor efficacy of a MUC1 peptide vaccine against breast cancer in MUC1 transgenic mice. Plos One. 14: e0224309 |